Gradalis - Crunchbase Company Profile & Funding

Q: Where is Gradalis's headquarters?

Gradalis is located in Carrollton, Texas, United States.

Q: When was the last funding round for Gradalis?

Gradalis closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Gradalis raised to date?

Gradalis has raised obfuscated.

Overview

Gradalis

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Gradalis

CB Rank

57374

Gradalis is engaged in manufacturing immunotherapy for the treatment of cancer.

Founded

obfuscation

Private

Grant

Carrollton, Texas, United States

11-50

www.gradalisinc.com

Biotechnology

Health Diagnostics

Manufacturing

Funding Rounds

Grant

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Steven Engle: CEO and Board Member
Ernie Bognar: Chief Operating Officer

Details

Legal Name

Gradalis, Inc.

Operating Status

Active

Company Type

For Profit

Founders

David Shanahan, John Nemunaitis

About the Company

Gradalis is a late stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer. We are developing Vigil, our proprietary immunotherapy platform in multiple advanced cancer indications with the lead program for the treatment of patients with Ewing's sarcoma.

Phone Number

214-442-8100

Contact Email

info@gradalisinc.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Vigil (Gemogenovatucel-T)

A personalized cancer immunotherapy that uses a patient’s own immune system to target and destroy cancer cells, primarily for ovarian cancer and other solid tumors.

Research & Development

Gradalis is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant
obfuscated obfuscation	Grant - Gradalis	1	obfuscated obfuscation	Cancer Prevention and Research Institute of Texas	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Cancer Prevention and Research Institute of Texas	Yes	Grant - Gradalis	—
Cancer Prevention and Research Institute of Texas	Yes	Grant - Gradalis	—
Cancer Prevention and Research Institute of Texas	Yes	Grant - Gradalis	—
Cancer Prevention and Research Institute of Texas	Yes	Grant - Gradalis	—
Cancer Prevention and Research Institute of Texas	Yes	Grant - Gradalis	—